Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients;Anticorpos anti-C1q, anticromatina/nucleossomo e anti-dsDNA em pacientes com lúpus eritematoso sistêmico juvenil

Revista Brasileira de Reumatologia

Volumn 52, Issue 6, 2012, Pages 976-981

  De Jesus, Adriana Almeida ^a   Campos, Lucia Maria Arruda ^a   Liphaus, Bernadete Lourdes ^a   Carneiro Sampaio, Magda ^a   Mangueira, Cristóvão Luis Pitangueira ^b   Rosseto, Eliane Aparecida ^b   Da Silva, Clovis Artur Almeida ^a   Scheinberg, Morton ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHROMATIN ANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNODIFFUSION; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CHILD; CHROMATIN; COMPLEMENT C1Q; DNA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; NUCLEOSOMES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84873022565     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042012000600015     Document Type: Article

References (19)

1. Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A. IgG autoantibodies to complement C1q in pediatriconset systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15(2):215-19.
2. Kozyro I, Perahud I, Sadallah S, Sukalo A, Titov L, Schifferli J et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 2006; 117(5):1663-8.
3. Jesus AA, Silva CA, Carneiro-Sampaio M, Sheinberg M, Mangueira CL, Marie SK et al. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus. Ann N Y Acad Sci 2009; 1173:235-8.
4. Wu FQ, Zhao Q, Cui XD, Zhang W. C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int 2011; 31(4):501-5.
5. Campos LM, Kiss MH, Scheinberg MA, Mangueira CL, Silva CA. Antinucleossomo antibodies in patients with juvenile systemic lupus erythematosus. Lupus 2006; 15(8):496-500.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erhytematosus. Arthritis Rheum 1997; 40(9):1725.
7. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2):288-91.
8. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005; 19(5):685-708.
9. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 2006; 21(11):3115-21.
10. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann N Y Acad Sci 2005; 1050:193-200.
11. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T et al. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum 2011; 63(8):2436-44.
12. Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 2011; 20(12):1267-74.
13. Carneiro-Sampaio M, Liphaus BL, Jesus AA, Silva CA, Oliveira JB, Kiss MH. Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. J Clin Immunol 2008; 28(Suppl 1):S34-41.
14. Flierman R, Daha MR. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis - a hypothesis. Mol Immunol 2007; 44(1-3):133-8.
15. Kiss E, Lakos G, Szegedi G, Poor G, Szodoray P. Anti-nucleossomo antibody, a reliable indicator for lupus nephritis. Autoimmunity 2009; 42(5):393-8.
16. Muller S, Dieker J, Tincani A, Meroni PL. Pathogenic antinucleossomo antibodies. Lupus 2008; 17(5):431-6.
17. Gómez-Puerta JA, Burlingame RW, Cervera R. Anticromatina (antinucleossomo) antibodies: diagnostic and clinical value. Autoimmun Rev 2008; 7(8):606-11.
18. Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P. Anti-nucleossomo and anticromatina antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Lupus 2009; 18(3):223-9.
19. O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW et al. Nucleossomos and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol Immunol 2011; 49(1-2):75-83.